The 2025-2030 World Outlook for Minimally Invasive Surgical Instruments

The 2025-2030 World Outlook for Minimally Invasive Surgical Instruments

This study covers the world outlook for minimally invasive surgical instruments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

In this report we define the sales of minimally invasive surgical instruments as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott, Acmi Circon, Actelion Pharmaceuticals, Aesculap, Alcon Laboratories, Applied Biomedical, LLC. (USA), ArthroCare, B. Braun Melsungen, Becton, Dickinson and Company, Biolitec, Biomet, Boston Scientific Corporation, California Resources Corporation (US), CONMED Corporation, Davol, DePuy Synthes, Encision, Ethicon, FUJIFILM Holdings Corporation, GE Healthcare, Given Imagin Ltd. (US), Hoya Corporation, Intuitive Surgical, Johnson & Johnson, Karl Storz, KLS Martin, Koninklijke Philips, Medical Devices Business Services, Inc. (US), Medtronic, Microline Surgical, Novatract Surgical Inc. (US), NuVasive, Olympus Corporation of America, OmniGuide Holdings, REMA Medizintechnik GmbH (Germany), Scanlan International, Siemens Healthcare, Smith & Nephew, Stryker (US), Surgical Innovations Group, Teleflex, and Zimmer Biomet. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).